SCHEMBL9539329

SCHEMBL9539329

Nc1nccc(Cc2cccs2)c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ TAAR1 Q96RJ0 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ADRA1D P25100 2/20 0.38
▸ ADCY10 Q96PN6 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ STAT3 P40763 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ NOS3 P29474 1/20 0.36
▸ NOS2 P35228 1/20 0.36
▸ PNP P00491 3/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9390272 0.81 PIK3CD (0.43) PIK3CDPIK3CBTAAR1CYP2C9ADRA1D
SCHEMBL9537854 0.74 TAAR1 (0.42) PIK3CDPIK3CBTAAR1CYP2C9ADRA1D
SCHEMBL7668747 0.73 LOXL2 (0.51) CYP2C9ADRA1DTSHRSMN1; SMN2KDM4E
SCHEMBL1543745 0.73 CYP2C9 (0.39) PIK3CDPIK3CBTAAR1CYP2C9ADRA1D
SCHEMBL3957456 0.72 — —
SCHEMBL7499087 0.72 LTA4H (0.43) NOS3NOS2
SCHEMBL9694376 0.72 CYP17A1 (0.44) CYP2C9TSHRSMN1; SMN2NOS3NOS2
SCHEMBL9387184 0.71 GAA (0.40) POLBNOS3NOS2PNPKDM4E
SCHEMBL11375889 0.71 PIK3CD (0.39) PIK3CDPIK3CBTAAR1ADRA1DADORA3
SCHEMBL2719810 0.70 KDM4E (0.50) PIK3CDPIK3CBTAAR1ADRA1DADCY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 — — EP disclosed
EP-0297661-B1 [(Bicyclic heterocyclyl)methyl and -hetero] substituted hexahydro-1H-azepines and pyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-16 — — EP disclosed
EP-0151824-B1 N-(4-PIPERIDINYL) BICYCLIC CONDENSED 2-IMIDAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1990-04-04 — — EP disclosed
EP-0145037-B1 N-(BICYCLIC HETEROCYCLYL)-4-PIPERIDINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1989-01-18 — — EP disclosed
EP-0297661-A1 [(Bicyclic heterocyclyl)methyl and -hetero] substituted hexahydro-1H-azepines and pyrrolidines JANSSEN PHARMACEUTICA N.V. (BE) 1989-01-04 — — EP disclosed
EP-0151824-A2 N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1985-08-21 — — EP disclosed
Send feedback